` 000513 (Livzon Pharmaceutical Group Inc) vs Shanghai Composite Comparison - Alpha Spread

000513
vs
Shanghai Composite

Over the past 12 months, has underperformed Shanghai Composite, delivering a return of -6% compared to the Shanghai Composite's 12% growth.

Stocks Performance
000513 vs Shanghai Composite

Loading

Performance Gap
000513 vs Shanghai Composite

Loading
000513
Shanghai Composite
Difference

Performance By Year
000513 vs Shanghai Composite

Loading
000513
Shanghai Composite
Add Stock

Competitors Performance
Livzon Pharmaceutical Group Inc vs Peers

Shanghai Composite
000513
LLY
JNJ
NOVO B
ROG
Add Stock

Livzon Pharmaceutical Group Inc
Glance View

Market Cap
32.8B CNY
Industry
Pharmaceuticals

Nestled within the bustling pharmaceutical landscape of China, Livzon Pharmaceutical Group Inc. has meticulously carved its path since its inception in 1985, blossoming into a formidable player in the industry. Based in Zhuhai, Guangdong Province, the company has steadily built a diversified portfolio across the pharmaceutical spectrum, focusing on both traditional Chinese medicine and modern biopharmaceutical products. Livzon leverages its robust research and development (R&D) capabilities to produce an extensive range of medications, catering primarily to major therapeutic areas such as cardiovascular, gastrointestinal, anti-infective, and oncology segments. With rigorous standards driving their production lines, they ensure premium quality, which has bolstered their reputation and allowed them to secure numerous patents and proprietary products. Livzon's revenue engine is fueled by its strategic blend of manufacturing prowess and a well-tuned distribution network. The company operates a comprehensive production chain, from raw material sourcing and pharmaceuticals manufacturing to extensive distribution channels stretching across domestic and global markets. It sustains strong collaborations with hospitals, medical institutions, and pharmacies, which facilitate widespread accessibility and market penetration. Additionally, Livzon invests heavily in innovation, aligning with global health demands through strategic partnerships and joint ventures, further pushing the boundaries of research. By balancing traditional medicinal wisdom with cutting-edge technologies, Livzon positions itself as an agile competitor in the ever-evolving pharmaceutical arena, continuously driving value creation and securing its foothold in the global marketplace.

Intrinsic Value
43.64 CNY
Undervaluation 19%
Intrinsic Value
Price
Back to Top